E85.4
Organ-limited amyloidosis
Clinical Classification Guidelines
Inclusion Terms
- Localized amyloidosis
- Transthyretin-related (ATTR) familial amyloid cardiomyopathy
Medical Intelligence & Overview
Organ-limited amyloidosis, classified under ICD-10 code E85.4, is a condition characterized by the abnormal buildup of amyloid proteins in a specific organ or tissue. Unlike systemic forms of amyloidosis that affect multiple organs throughout the body, this type is confined to a particular area, leading to localized symptoms and potential organ dysfunction. A well-known example within this category is transthyretin-related (ATTR) familial amyloid cardiomyopathy, which predominantly impacts the heart.
Causes & Symptoms
Clinical Causes: Genetic mutations leading to the production of abnormal transthyretin protein Inherited forms of amyloidosis that result in the deposition of amyloid in specific organs Localized abnormal protein production that does not spread systemically
Key Symptoms: Organ-specific symptoms depending on the affected area: - Heart involvement may lead to symptoms of heart failure such as shortness of breath, fatigue, and swelling in the legs - Skin deposits may cause lumps or plaques - Soft tissue areas may exhibit swelling or firmness - In some cases, organ size may increase or function may become impaired
Diagnostic & Treatment
Diagnosis Path: Detailed medical history and physical examination focusing on the affected organ Imaging studies such as echocardiograms, MRI, or CT scans to visualize organ abnormalities Biopsy of the affected tissue showing amyloid deposits with special staining techniques Laboratory tests to rule out systemic amyloidosis and assess organ function Genetic testing, especially in familial cases like ATTR amyloidosis
Treatment Protocols: Management of symptoms and preservation of organ function Medications to treat underlying causes when available, such as stabilizers for transthyretin protein in hereditary cases Organ-specific interventions, including medications, lifestyle adjustments, or devices for heart failure In some instances, advanced therapies like organ transplantation or emerging amyloid-targeted treatments could be considered Regular monitoring to assess disease progression and organ health
Clinical Advice & FAQs
Billing Guidance
Is E85.4 a billable ICD-10 code?
Yes, E85.4 is a specific, billable code that can be used to indicate a diagnosis for reimbursement purposes.
Documentation
How do I report E85.4?
Clinical documentation must specify the nature of Organ-limited amyloidosis and any associated comorbidities for accurate reporting.
Cite this Clinical Reference